논문 및 학회자료

Population pharmacokinetics of FM101 in healthy volunteers and long-term safety prediction: phase 1 study (PAGE 2023)

Admin │ 2023-05-12

HIT

528



이전글 Preclinical characterization of FM101, a first-in-class A3 adenosine receptor mo...
다음글 6′-β-Fluoro-homoaristeromycin and 6′-fluoro-homoneplanocin A are potent i...